NO20010622D0 - Novel carboxylic acid derivatives bearing keto side chains, their preparation and their use as endothelin receptor antagonists - Google Patents

Novel carboxylic acid derivatives bearing keto side chains, their preparation and their use as endothelin receptor antagonists

Info

Publication number
NO20010622D0
NO20010622D0 NO20010622A NO20010622A NO20010622D0 NO 20010622 D0 NO20010622 D0 NO 20010622D0 NO 20010622 A NO20010622 A NO 20010622A NO 20010622 A NO20010622 A NO 20010622A NO 20010622 D0 NO20010622 D0 NO 20010622D0
Authority
NO
Norway
Prior art keywords
preparation
carboxylic acid
side chains
acid derivatives
receptor antagonists
Prior art date
Application number
NO20010622A
Other languages
Norwegian (no)
Other versions
NO20010622L (en
Inventor
Wilhelm Amberg
Rolf Jansen
Georg Kettschau
Stefan Hergenroeder
Manfred Raschack
Liliane Unger
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO20010622L publication Critical patent/NO20010622L/en
Publication of NO20010622D0 publication Critical patent/NO20010622D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20010622A 1998-08-10 2001-02-06 Novel carboxylic acid derivatives bearing keto side chains, their preparation and their use as endothelin receptor antagonists NO20010622D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19836044A DE19836044A1 (en) 1998-08-10 1998-08-10 New 2-(hetero)aryl-alkanoic acid derivatives, useful as mixed endothelin receptor antagonists, e.g. for treating cardiac insufficiency, restenosis, hypertension or prostate cancer
PCT/EP1999/005728 WO2000009489A1 (en) 1998-08-10 1999-08-07 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists

Publications (2)

Publication Number Publication Date
NO20010622L NO20010622L (en) 2001-02-06
NO20010622D0 true NO20010622D0 (en) 2001-02-06

Family

ID=7876981

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010622A NO20010622D0 (en) 1998-08-10 2001-02-06 Novel carboxylic acid derivatives bearing keto side chains, their preparation and their use as endothelin receptor antagonists

Country Status (22)

Country Link
EP (1) EP1104410A1 (en)
JP (1) JP2002522531A (en)
KR (1) KR20010072378A (en)
CN (1) CN1323298A (en)
AR (1) AR020147A1 (en)
AU (1) AU5374199A (en)
BG (1) BG105236A (en)
BR (1) BR9912889A (en)
CA (1) CA2340167A1 (en)
CO (1) CO5261504A1 (en)
DE (1) DE19836044A1 (en)
HK (1) HK1042086A1 (en)
HR (1) HRP20010164A2 (en)
HU (1) HUP0104007A3 (en)
ID (1) ID27965A (en)
IL (1) IL140915A0 (en)
NO (1) NO20010622D0 (en)
PL (1) PL345998A1 (en)
SK (1) SK832001A3 (en)
TR (1) TR200100427T2 (en)
WO (1) WO2000009489A1 (en)
ZA (1) ZA200101975B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19924892A1 (en) * 1999-06-01 2000-12-07 Basf Ag New carboxylic acid derivatives with aryl-substituted nitrogen heterocycles, their production and use as endothelin receptor antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19636046A1 (en) * 1996-09-05 1998-03-12 Basf Ag New carboxylic acid derivatives, their production and use as mixed ET¶A¶ / ET¶B¶ receptor antagonists

Also Published As

Publication number Publication date
DE19836044A1 (en) 2000-02-17
PL345998A1 (en) 2002-01-14
NO20010622L (en) 2001-02-06
WO2000009489A1 (en) 2000-02-24
HUP0104007A3 (en) 2002-12-28
IL140915A0 (en) 2002-02-10
TR200100427T2 (en) 2001-07-23
EP1104410A1 (en) 2001-06-06
AU5374199A (en) 2000-03-06
CA2340167A1 (en) 2000-02-24
SK832001A3 (en) 2001-11-06
HUP0104007A2 (en) 2002-05-29
AR020147A1 (en) 2002-04-10
CN1323298A (en) 2001-11-21
BG105236A (en) 2001-12-29
KR20010072378A (en) 2001-07-31
JP2002522531A (en) 2002-07-23
HRP20010164A2 (en) 2002-04-30
ID27965A (en) 2001-05-03
ZA200101975B (en) 2002-03-11
HK1042086A1 (en) 2002-08-02
CO5261504A1 (en) 2003-03-31
BR9912889A (en) 2001-05-08

Similar Documents

Publication Publication Date Title
NO20015113L (en) New compounds, their preparation and use
NO991079D0 (en) Azinyloxy and phenoxy-diaryl-carboxylic acid derivatives, their preparation and their use as leafy ETA / ETB endothelin receptor antagonists
DK1157005T3 (en) 3-phenylpyridine derivatives and their use as NK-1 receptor antagonists
NO991761D0 (en) New piperidine cotocarboxylic acid derivatives, their preparation and use
NO981522L (en) Amino acid derivatives, their preparation and use as endothelin antagonists
NO20052124D0 (en) New 1,4-diazabicycloalkane derivatives, their preparation and use
NO20023146D0 (en) Substituted phenyl-piperazine derivatives, their preparation and use
NO20002124D0 (en) Novel Carboxylic Acid Derivatives with Amide Side Chains, Their Preparation and Use as Endothelin Receptor Antagonists
DK1043307T3 (en) 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use
NO984714D0 (en) New carboxylic acid derivatives, their preparation and use
NO984713L (en) New carboxylic acid derivatives, their preparation and use
NO20004144D0 (en) Heterocyclic compounds, their preparation and use as tachykinin receptor antagonists
NO20014224L (en) 4-heterocyclysulfonamidyl-6-methoxy-5- (2-methoxy-phenoxy) -2-pyridyl-pyrimidine derivatives, preparation thereof and use as endothelin receptor antagonists
NO992976D0 (en) Heterocyclic carboxylic acid derivatives, preparation and use thereof as endothelin receptor antagonists
NO996268D0 (en) New <beta> -amino- and <beta> -azidocarboxylic acid derivatives, their preparation and use as endothelin receptor antagonists
NO20010622D0 (en) Novel carboxylic acid derivatives bearing keto side chains, their preparation and their use as endothelin receptor antagonists
NO20001077D0 (en) Novel Carboxylic Acid Derivatives, Their Preparation and Use as Mixed ETA / ETB Endothelin Receptor Antagonists
NO20013000D0 (en) New <beta> -amide and <beta> -sulfonamide carboxylic acid derivatives, their preparation and use as endothelin receptor antagonists
NO20020254D0 (en) Novel carboxylic acid derivatives with 5,6-substituted pyrimidine ring, preparation and use thereof as endothelin receptor antagonists
NO20004075D0 (en) Substituted pyrimidin-2-yloxy-carboxylic acid derivatives, their preparation and their use as endothelin antagonists
NO20040426L (en) Novel imidazolidine derivatives and their preparation and use as VLA-4 antagonists.
NO20023188D0 (en) New heteroaryl derivatives, their preparation and use
NO20001782L (en) 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use
DK1235809T3 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as drugs
ZA9810425B (en) Novel heterocyclically substituted Ó-hydroxycarboxylic acid derivatives, their preparation and use as endothelin receptor antagonists.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application